Lifestyle and dietary correlates of plasma insulin-like growth factor binding protein-1 (IGFBP-1), leptin, and C-peptide: The multiethnic cohort

被引:13
|
作者
Henderson, Katherine DeLellis [1 ]
Rinaldi, Sabina
Kaaks, Rudolf
Kolonel, Laurence
Henderson, Brian
Le Marchand, Loiec
机构
[1] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
[2] Int Agcy Res Canc, F-69372 Lyon, France
[3] German Canc Res Ctr, DKFZ, Div Canc Epidemiol, D-6900 Heidelberg, Germany
[4] Univ Hawaii, Canc Res Ctr, Honolulu, HI 96822 USA
来源
关键词
D O I
10.1080/01635580701328073
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circulating insulin-like growth factor binding protein I (IGFBP-1), leptin, and insulin are 3 proteins modified by obesity and have been associated with cancer at several sites in past studies. We conducted a cross-sectional study to describe the correlation of these proteins with gender, race/ethnicity, anthropometric indexes, and dietary and lifestyle factors. We measured fasting plasma levels of IGFBP-1, leptin, and C-peptide, used here as a stable measure of insulin secretion, in a random sample of 450 male and 352 postmenopausal female Hawaii and Los Angeles Multiethnic Cohort Study (MEC) participants (age range 47-82 yr at blood draw). Through a series of multiple linear regressions, we found that the most parsimonious model for plasma IGFBP-1 included inverse associations with age, body mass index (BMI), and regular soda intake. A term for interaction between age and BMI was positively associated with plasma IGFBP-1. Adjusted mean plasma leptins were highest among Whites and African Americans and lowest among Hawaiians and Japanese Leptin was also inversely associated with age and positively associated with the interaction between age and race/ethnicity, female gender, and BMI. A model with only race/ethnicity and BMI (positive association) was best for plasma C-peptide. Adjusted means for C-peptide were highest for Japanese and Whites and lowest for African Americans. The overall percent of variance in protein levels explained by these models was low for IGFBP-I (R-2 = 0. 17) and C-peptide (R-2 = 0. 11) and higher for leptin (R-2 = 0.57). We saw no clear correlation between racial/ethnic trends in protein levels with those of colorectal, breast, or prostate cancer incidence rates in the MEC. Research to clarify factors associated with determination of these proteins and their relationship with cancer etiology is warranted.
引用
收藏
页码:136 / 145
页数:10
相关论文
共 50 条
  • [1] Insulin-like growth factor binding protein-1 (IGFBP-1) during normal pregnancy
    Larsson, Anders
    Palm, Maria
    Basu, Samar
    Axelsson, Ove
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (02) : 129 - 132
  • [2] Insulin-like growth factor-binding protein-1 (IGFBP-1) in the human ovary
    Suikkari, Anne-Maria
    Angervo, Maarit
    Koistinen, Ritta
    Jalkanen, Jyrki
    Seppaelae, Markku
    Annals of the New York Academy of Sciences, 1991, 626
  • [3] Physiological differences in insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation in IGFBP-1 transgenic mice
    Sakai, K
    D'Ercole, AJ
    Murphy, LJ
    Clemmons, DR
    DIABETES, 2001, 50 (01) : 32 - 38
  • [4] Differential proteolysis of insulin-like growth factor binding protein-1 (IGFBP-1) in pregnancy
    Hills, Frank A.
    Iles, Ray K.
    Sullivan, Mark H.
    JOURNAL OF PERINATAL MEDICINE, 2013, 41 (03) : 241 - 249
  • [5] Delta insulin-like growth factor binding protein-1 (ΔIGFBP-1): a marker of hepatic insulin resistance?
    Borai, Anwar
    Livingstone, Callum
    Heald, Adrian H.
    Oyindamola, Yusuf
    Ferns, Gordon
    ANNALS OF CLINICAL BIOCHEMISTRY, 2014, 51 (02) : 269 - 276
  • [6] Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) as a Biomarker of Cardiovascular Disease
    Lewitt, Moira S.
    Boyd, Gary W.
    BIOMOLECULES, 2024, 14 (11)
  • [7] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 (IGFBP-1) LEVELS IN TURNER SYNDROME
    CIANFARANI, S
    HOLLY, JMP
    PASQUINO, AM
    VACCARO, F
    SPADONI, GL
    BERNARDINI, S
    SEGNI, M
    BOSCHERINI, B
    HORMONE AND METABOLIC RESEARCH, 1992, 24 (11) : 537 - 540
  • [8] RESPONSES OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 (IGFBP-1) AND THE IGFBP-3 COMPLEX TO ADMINISTRATION OF INSULIN-LIKE GROWTH FACTOR-I
    BAXTER, RC
    HIZUKA, N
    TAKANO, K
    HOLMAN, SR
    ASAKAWA, K
    ACTA ENDOCRINOLOGICA, 1993, 128 (02): : 101 - 108
  • [9] OCTREOTIDE STIMULATES INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 (IGFBP-1) LEVELS IN ACROMEGALY
    EZZAT, S
    REN, SG
    BRAUNSTEIN, GD
    MELMED, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (02): : 441 - 443
  • [10] Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility
    Zhang, XH
    Yee, D
    CANCER RESEARCH, 2002, 62 (15) : 4369 - 4375